Advisors Preferred’s Globus Medical GMED Stock Holding History

Advisors Preferred’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-444	Closed	-$22K	–	234
2018 Q1	$22K	Buy	+444	New	+$20.9K	0.01%	212

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Advisors Preferred's GMED Position: Q2 2018 in Review

Advisors Preferred sold out of Globus Medical (GMED) in Q2 2018, closing a stake of 444 shares — an estimated $22K sold.

Advisors Preferred first reported a position in GMED in Q1 2018 and held it in 1 quarter. The position peaked at $22K in Q1 2018. 290 funds tracked by Wall St. Rank hold GMED as of Q2 2018.

Advisors Preferred reported no remaining Globus Medical position as of Q2 2018 after selling out during the quarter.
Advisors Preferred sold 444 Globus Medical shares in Q2 2018, an estimated $22K.
Advisors Preferred first reported a position in Globus Medical in Q1 2018 and held it in 1 quarter.
Advisors Preferred's Globus Medical position peaked at $22K in Q1 2018.
290 funds tracked by Wall St. Rank held Globus Medical as of Q2 2018.

Based on Advisors Preferred's 13F filing for Q2 2018, filed 7 Aug 2018.